Updated: 27th July 2026
Reviewed by: David Small BSc (Hons), MSc, MTOPRA (Founder and CEO)
What Does Medical Device Registration Mean?
The term medical device registration is often used as though it refers to a single regulatory process. In reality, it describes several different activities that vary depending on the country where a medical device or in vitro diagnostic (IVD) is being placed on the market. Registration requirements differ between jurisdictions and may include product registration, manufacturer registration, regulatory database registration or the appointment of an authorised representative.
Many manufacturers mistakenly assume that obtaining CE marking or UKCA marking automatically registers their device for sale. In most cases, this is not correct. While conformity assessment demonstrates that a device meets the applicable regulatory requirements, additional registration obligations may still apply before the product can be legally placed on the market.
For example, manufacturers placing devices on the European Union market under the EU MDR or IVDR may need to complete EUDAMED registrations, obtain a Single Registration Number (SRN), assign Unique Device Identifiers (UDIs) and appoint an EU Authorised Representative if they are based outside the EU. Similarly, manufacturers placing devices on the Great Britain market must register their devices with the Medicines and Healthcare products Regulatory Agency (MHRA), while overseas manufacturers are generally required to appoint a UK Responsible Person.
Outside Europe, many countries operate their own registration systems. In the United States, manufacturers must comply with the FDA’s establishment registration and device listing requirements, while Australia requires many devices to be included on the Australian Register of Therapeutic Goods (ARTG). Other jurisdictions have their own national registration processes, timelines and documentation requirements.
Because the phrase medical device registration can refer to several different regulatory obligations, it is important to first identify which market you intend to enter and which registration activities apply to your product. Understanding these requirements early in the development process helps manufacturers avoid delays, prevent regulatory non-compliance and achieve a smoother route to market.
Registration Requirements Vary by Market
The table below provides a high-level overview of the main registration activities required in some of the world’s largest medical device markets.
| Market | Primary Registration Requirements |
|---|---|
| European Union | CE marking, EUDAMED registration, UDI assignment, SRN (where applicable), EU Authorised Representative for non-EU manufacturers |
| Great Britain | MHRA device registration, UK Responsible Person for overseas manufacturers |
| Northern Ireland | EU MDR/IVDR requirements together with UK-specific obligations where applicable |
| United States | FDA Establishment Registration and Device Listing |
| Australia | Inclusion in the Australian Register of Therapeutic Goods (ARTG) |
| Other International Markets | National registration requirements vary depending on local regulations |
In the following sections, we’ll explain each of these registration pathways in more detail and show you which requirements apply depending on your product and target market.
Which Medical Device Registrations Do You Need?
The registration requirements that apply to your medical device or IVD depend on several factors, including the market where you intend to sell your product, whether you are based inside or outside that market, the classification of your device and the applicable regulatory framework. There is no single registration process that applies to every manufacturer or every jurisdiction.
The first step is to identify where you plan to place your product on the market. Different countries operate different regulatory systems, each with their own registration requirements, regulatory authorities and conformity assessment procedures. While some principles are similar, the documentation, timelines and responsibilities can vary considerably.
For manufacturers entering multiple international markets, it is common to complete several registration processes in parallel. For example, a manufacturer selling the same device in the European Union, Great Britain and the United States may need to obtain CE marking, register the device with the MHRA, comply with FDA establishment registration and device listing requirements, and appoint market-specific regulatory representatives where required.
The following decision guide provides a simplified overview of the most common registration pathways.
Registration Decision Guide
| If you want to sell in… | You will typically need… | Learn More |
|---|---|---|
| 🇪🇺 European Union | CE marking, EUDAMED registration, UDI assignment, EU Authorised Representative (for non-EU manufacturers) | MDR for Beginners, EUDAMED, UDI, EU Authorised Representative |
| 🇬🇧 Great Britain | MHRA device registration and a UK Responsible Person (for overseas manufacturers) | UK Responsible Person |
| 🇬🇧 Northern Ireland | Compliance with the EU MDR or IVDR together with applicable UK legislation | MDR for Beginners |
| 🇺🇸 United States | FDA Establishment Registration and Device Listing (plus applicable premarket requirements) | FDA Regulatory Services |
| 🇦🇺 Australia | Inclusion on the Australian Register of Therapeutic Goods (ARTG) | ARTG Guidance |
| 🌍 Multiple Markets | A coordinated global regulatory strategy covering each target market | Patient Guard Regulatory Consultancy |
What Determines Which Registrations Apply?
Before beginning any registration process, manufacturers should consider the following questions:
- Which country or region will the device be marketed in?
- Is the product a medical device or an in vitro diagnostic (IVD)?
- What is the regulatory classification of the device?
- Is the manufacturer established within the target market?
- Does the device require a Notified Body or other conformity assessment?
- Are product registration, manufacturer registration or both required?
- Is an Authorised Representative or UK Responsible Person legally required?
Answering these questions early helps manufacturers identify the correct regulatory pathway, avoid unnecessary delays and ensure that registration activities are completed in the correct order.
The following sections explain the registration requirements for the European Union, Great Britain and other major international markets, together with the roles of CE marking, EUDAMED, UDI, MHRA registration and regulatory representatives.
Medical Device Registration in the European Union
The European Union has one of the world’s most comprehensive regulatory frameworks for medical devices and in vitro diagnostic medical devices. Rather than relying on a single registration process, manufacturers must comply with several interconnected regulatory requirements before placing a product on the EU market.
The exact obligations depend on factors such as the type of device, its classification, whether the manufacturer is established inside or outside the European Union, and whether a Notified Body is involved in the conformity assessment process. While not every manufacturer will need to complete every registration activity, understanding how these requirements fit together is essential for achieving and maintaining compliance.
The Main EU Registration Requirements
CE Marking
CE marking demonstrates that a medical device or IVD complies with the applicable requirements of the EU Medical Device Regulation (MDR) or In Vitro Diagnostic Medical Device Regulation (IVDR). Depending on the classification of the product, manufacturers may be able to self-declare conformity or may need to undergo assessment by a Notified Body before affixing the CE mark.
CE marking allows a compliant device to be placed on the European market, but it is only one part of the wider regulatory process.
Need Help Understanding CE Marking?
Medical device registration often begins with demonstrating conformity under the applicable European legislation. For a step-by-step explanation of classification, conformity assessment, Technical Documentation, Notified Bodies and placing a compliant device on the market, read our CE Marking for Medical Devices Guide.
EUDAMED Registration
EUDAMED is the European database established to improve transparency, traceability and coordination between manufacturers, Authorised Representatives, Notified Bodies and Competent Authorities.
Depending on the regulatory requirements that apply, manufacturers may need to register themselves, economic operators and medical devices within EUDAMED using the appropriate modules.
Confused About EUDAMED Registration?
EUDAMED plays a central role in medical device transparency and traceability under the EU MDR and IVDR. Learn how the European database works, who needs to register, the different EUDAMED modules and what manufacturers need to do to remain compliant in our Complete Guide to EUDAMED.
Unique Device Identification (UDI)
Most medical devices and IVDs require a Unique Device Identifier (UDI) to improve traceability throughout the product lifecycle. UDI supports market surveillance, vigilance activities and device identification, while also forming an important part of EUDAMED registration.
Manufacturers are responsible for assigning UDIs in accordance with the applicable MDR or IVDR requirements before placing eligible devices on the market.
Need to Understand UDI Requirements?
Unique Device Identification (UDI) is a fundamental requirement under the EU MDR, IVDR and many international regulatory frameworks, helping improve traceability, patient safety and post-market surveillance. Learn how UDI-DI, UDI-PI, issuing agencies, labelling requirements and global UDI systems work in our Medical Device UDI for Beginners Guide.
EU Authorised Representative
Manufacturers established outside the European Union must generally appoint an EU Authorised Representative before placing devices on the EU market. The Authorised Representative acts on behalf of the manufacturer for certain regulatory obligations and serves as an important point of contact for Competent Authorities.
The appointment of an Authorised Representative is a legal requirement for most non-EU manufacturers and forms part of the overall regulatory framework rather than a standalone registration process.
Choosing an EU Authorised Representative or Importer?
If you're based outside the European Union, appointing the right Authorised Representative and Importer is essential for accessing the EU market. Learn about their legal responsibilities under the EU MDR and IVDR, what to look for in a compliant partner and the common mistakes to avoid in our Guide to Selecting an EU Authorised Representative or Importer.
Bringing the Requirements Together
Although these activities are often described collectively as medical device registration, they each serve a different purpose within the EU regulatory framework.
| Requirement | Primary Purpose |
|---|---|
| CE Marking | Demonstrates conformity with the MDR or IVDR before placing a device on the market. |
| EUDAMED | Improves regulatory transparency and facilitates the registration of economic operators and devices. |
| UDI | Enables unique identification and traceability of individual devices throughout their lifecycle. |
| EU Authorised Representative | Represents non-EU manufacturers and fulfils specific legal obligations under the MDR and IVDR. |
Together, these requirements create a regulatory system that helps ensure medical devices placed on the European market are safe, effective and traceable throughout their lifecycle.
Medical Device Registration in Great Britain
Medical devices placed on the market in Great Britain (England, Scotland and Wales) are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Unlike the European Union, where several registration activities form part of a broader regulatory framework, Great Britain requires most medical devices and IVDs to be registered directly with the MHRA before they can be legally placed on the market.
The registration requirements depend on the type of device, the location of the manufacturer and the applicable UK medical device legislation. Manufacturers should also be aware that the regulatory requirements for Northern Ireland differ from those in Great Britain because of the Windsor Framework.
The Main UK Registration Requirements
MHRA Device Registration
Before placing most medical devices or IVDs on the Great Britain market, manufacturers must register their products with the MHRA. The registration process records important information about the manufacturer and the devices being supplied, helping the regulator support market surveillance, vigilance and patient safety activities.
Registration with the MHRA is a legal requirement and should not be confused with CE marking or UKCA marking.
UK Responsible Person
Manufacturers based outside the United Kingdom are generally required to appoint a UK Responsible Person (UKRP) before placing devices on the Great Britain market.
The UK Responsible Person acts on behalf of the overseas manufacturer and has a number of legal responsibilities, including maintaining regulatory documentation, cooperating with the MHRA and ensuring devices are correctly registered where required.
Do You Need a UK Responsible Person?
Manufacturers based outside Great Britain must appoint a UK Responsible Person (UKRP) before placing most medical devices and IVDs on the GB market. Learn who needs a UKRP, the legal responsibilities of the role, MHRA registration requirements and how to choose a compliant regulatory partner in our Complete Guide to the UK Responsible Person.
UKCA Marking and CE Marking
Depending on the applicable transitional arrangements and product type, devices placed on the Great Britain market may require UKCA marking or may continue to rely on recognised CE marking for a defined period. Manufacturers should always confirm the latest regulatory requirements before placing products on the market.
Although conformity marking demonstrates compliance with the relevant legislation, manufacturers must still ensure that all applicable registration obligations have been fulfilled.
Great Britain vs Northern Ireland
One of the most common areas of confusion is the difference between Great Britain and Northern Ireland.
| Market | Primary Regulatory Requirements |
|---|---|
| Great Britain (England, Scotland and Wales) | MHRA device registration together with the applicable UK medical device legislation. |
| Northern Ireland | Devices generally follow the EU MDR or IVDR framework, including CE marking requirements, due to the Windsor Framework. |
Understanding which regulatory framework applies is essential before beginning any registration process, particularly for manufacturers supplying products throughout the United Kingdom.
The next section explains how medical device registration differs in other major international markets, including the United States, Australia and other global jurisdictions.
Medical Device Registration in Other International Markets
While the European Union and Great Britain have their own regulatory systems, manufacturers expanding internationally must comply with the registration requirements of each target market. Every country operates its own regulatory framework, and the approvals, registrations and documentation required can vary significantly.
Many international regulators recognise globally accepted standards such as ISO 13485 and ISO 14971, but there is no universal medical device registration process. Manufacturers planning to sell products in multiple countries should develop a regulatory strategy that considers each market individually while maintaining a consistent quality management system and technical documentation.
Common International Registration Systems
The table below provides an overview of some of the world’s largest medical device markets and their primary registration requirements.
| Market | Primary Regulatory Authority | Typical Registration Requirements |
|---|---|---|
| 🇺🇸 United States | Food and Drug Administration (FDA) | Establishment Registration, Device Listing and, where applicable, 510(k), De Novo or PMA submission. |
| 🇦🇺 Australia | Therapeutic Goods Administration (TGA) | Inclusion in the Australian Register of Therapeutic Goods (ARTG) before supply. |
| 🇨🇦 Canada | Health Canada | Medical Device Licence (where applicable) and establishment licensing requirements. |
| 🇨🇭 Switzerland | Swissmedic | Swiss regulatory requirements, including the appointment of a Swiss Authorised Representative for many overseas manufacturers. |
| 🌍 Other Markets | National Competent Authorities | Country-specific registration, product approvals and regulatory representatives where required. |
Planning a Global Regulatory Strategy
Expanding into international markets is rarely a matter of completing a single registration. Manufacturers should first identify:
- The countries where the device will be marketed.
- Whether local representation is legally required.
- The device classification in each jurisdiction.
- Whether existing clinical or performance evidence is sufficient.
- Whether additional testing or regulatory submissions are required.
- The expected registration timelines for each market.
Developing a coordinated regulatory strategy helps avoid duplicated work, reduces time to market and ensures that technical documentation can support submissions across multiple jurisdictions wherever possible.
Start with Your Primary Market
For many manufacturers, it is more efficient to establish compliance in one major regulatory market before expanding internationally. For example, obtaining CE marking under the EU MDR or IVDR and implementing an ISO 13485 Quality Management System often provides a strong foundation for future registrations in other jurisdictions, although additional country-specific requirements will still need to be met.
The next section explains one of the most common misconceptions in medical device regulation — the difference between CE marking and medical device registration.
What's the Difference Between CE Marking and Medical Device Registration?
One of the most common misconceptions in medical device regulation is that CE marking and medical device registration are the same thing. Although they are closely related, they serve different purposes within the regulatory process.
In simple terms, CE marking demonstrates that a medical device complies with the applicable requirements of the EU Medical Device Regulation (MDR) or In Vitro Diagnostic Medical Device Regulation (IVDR). Medical device registration, on the other hand, refers to the administrative and regulatory activities that allow manufacturers, devices and economic operators to be recognised by the relevant Competent Authorities before products are placed on the market.
Obtaining CE marking does not automatically complete every registration requirement. Depending on the applicable legislation and the markets where the device will be sold, manufacturers may also need to register economic operators, assign Unique Device Identifiers (UDIs), register devices within EUDAMED where applicable, appoint an EU Authorised Representative or complete national registration requirements such as MHRA device registration in Great Britain.
Understanding the distinction helps manufacturers develop an appropriate regulatory strategy and avoid delays when bringing products to market.
CE Marking vs Medical Device Registration
| CE Marking | Medical Device Registration |
|---|---|
| Demonstrates conformity with the applicable legislation. | Records manufacturers, economic operators or devices with the relevant regulatory authority. |
| Required before most devices can be placed on the EU market. | Requirements vary depending on the country and regulatory framework. |
| May require assessment by a Notified Body for higher-risk devices. | May involve MHRA registration, EUDAMED registration, FDA Establishment Registration, ARTG inclusion or other national registration systems. |
| Focuses on demonstrating the safety and performance of the device. | Focuses on regulatory oversight, traceability and market surveillance. |
| Results in the device being eligible to bear the CE mark. | Results in the manufacturer or device being recorded within the applicable regulatory system. |
Both Are Essential Parts of Market Access
Rather than viewing CE marking and medical device registration as separate processes, manufacturers should think of them as complementary elements of regulatory compliance.
A successful route to market typically involves:
- Determining whether the product is a medical device or IVD.
- Identifying the applicable regulatory framework.
- Demonstrating conformity with the relevant legislation.
- Completing any required conformity assessment activities.
- Fulfilling the applicable registration requirements for each target market.
- Maintaining ongoing compliance through post-market surveillance, vigilance and regulatory updates.
Following this structured approach helps manufacturers avoid common compliance issues while ensuring devices remain legally placed on the market throughout their lifecycle.
Want to understand the complete CE marking process? Explore our comprehensive CE Marking for Medical Devices Guide, which explains classification, conformity assessment, Technical Documentation, Notified Bodies and the steps required to place a compliant medical device on the European market.
How to Prepare for Medical Device Registration
Successful medical device registration begins long before a product is submitted to a regulatory authority. Whether you are seeking CE marking under the EU MDR, registering a device with the MHRA or expanding into international markets, early regulatory planning can significantly reduce delays, minimise compliance risks and avoid costly rework.
Many registration applications are delayed because manufacturers discover late in the development process that key documentation is incomplete, the device has been incorrectly classified or additional testing is required. Developing a clear regulatory strategy from the outset helps ensure that the appropriate evidence is generated before registration activities begin.
Key Steps Before Registering Your Medical Device
Although the exact requirements vary between jurisdictions, manufacturers should normally complete the following activities before beginning the registration process.
| Step | Why It Matters |
|---|---|
| Confirm the product is a medical device or IVD | Determines whether medical device regulations apply. |
| Determine the correct classification | Defines the applicable regulatory pathway and conformity assessment route. |
| Establish the intended purpose | Influences classification, regulatory requirements and supporting evidence. |
| Prepare Technical Documentation | Demonstrates compliance with the applicable legislation. |
| Complete Risk Management | Identifies, evaluates and controls risks throughout the product lifecycle. |
| Perform Clinical or Performance Evaluation | Demonstrates that the device achieves its intended purpose while remaining safe and effective. |
| Implement an ISO 13485 Quality Management System | Supports consistent compliance and ongoing regulatory obligations. |
| Identify market-specific registration requirements | Ensures all applicable registrations are completed before market access. |
Build Your Registration Strategy Around the Entire Product Lifecycle
Medical device registration should not be viewed as a one-off administrative task. Most regulatory authorities expect manufacturers to maintain compliance throughout the entire lifecycle of the device.
This includes:
- Maintaining Technical Documentation.
- Updating Clinical Evaluation or Performance Evaluation where required.
- Reviewing Risk Management documentation.
- Monitoring post-market performance.
- Reporting serious incidents where applicable.
- Implementing corrective actions when necessary.
- Keeping registration information up to date following significant changes.
By considering these activities from the beginning of product development, manufacturers can create a regulatory strategy that supports both initial market access and long-term compliance.
Common Documents Required Before Registration
While documentation requirements differ between jurisdictions, manufacturers will often need some or all of the following:
- Technical Documentation or Technical File
- Quality Management System documentation
- Risk Management File
- Clinical Evaluation Report (CER) or Performance Evaluation Report (PER)
- Biological Evaluation (where applicable)
- Device labelling and Instructions for Use (IFU)
- Declaration of Conformity
- UDI information (where applicable)
Exactly which documents are required depends on the applicable legislation, device classification and target market.
The next section explains the most common mistakes manufacturers make during the medical device registration process and how they can be avoided.
The Medical Device Registration Process
Although registration requirements differ between countries, most manufacturers follow a similar sequence of activities before a medical device or IVD can be legally placed on the market. Understanding this process helps reduce delays, ensures regulatory requirements are completed in the correct order and provides a structured approach to achieving market access.
The exact steps will vary depending on the jurisdiction, device classification and regulatory pathway, but the following process reflects the journey followed by most manufacturers.
Typical Medical Device Registration Process
| Stage | Activity | Purpose |
|---|---|---|
| 1 | Determine whether the product is a medical device or IVD | Establish whether medical device regulations apply. |
| 2 | Classify the device | Identify the correct regulatory pathway and conformity assessment route. |
| 3 | Define the intended purpose | Determines the applicable regulatory requirements and supporting evidence. |
| 4 | Prepare Technical Documentation | Demonstrates compliance with the applicable legislation. |
| 5 | Complete conformity assessment | Includes self-declaration or Notified Body assessment where required. |
| 6 | Obtain conformity marking | CE marking, UKCA marking or other applicable regulatory approval. |
| 7 | Complete market-specific registrations | MHRA registration, EUDAMED activities, FDA Establishment Registration, ARTG inclusion or other applicable registrations. |
| 8 | Maintain post-market compliance | Continue regulatory compliance through PMS, vigilance and ongoing updates. |
Registration Is Not the Final Step
Many manufacturers view registration as the end of the regulatory journey. In reality, it marks the beginning of a device’s regulated lifecycle.
Once a device has been placed on the market, manufacturers must continue to meet their regulatory obligations. Depending on the applicable legislation, this may include:
- Maintaining Technical Documentation.
- Updating Risk Management documentation.
- Reviewing Clinical or Performance Evaluation.
- Monitoring post-market performance.
- Reporting serious incidents to the appropriate Competent Authorities.
- Implementing corrective and preventive actions (CAPA).
- Updating registration information when significant changes occur.
Maintaining compliance throughout the product lifecycle is just as important as obtaining the initial registrations.
Registration Activities Often Overlap
Rather than being completed one after another, many registration activities take place simultaneously.
For example, while Technical Documentation is being prepared, manufacturers are often also:
- Implementing an ISO 13485 Quality Management System.
- Completing Risk Management activities.
- Preparing device labelling and Instructions for Use.
- Assigning Unique Device Identifiers (UDIs).
- Planning market-specific registrations.
- Preparing Clinical or Performance Evaluation documentation.
Taking a coordinated approach helps reduce duplication of work and shortens the overall time to market.
In the next section, we’ll look at the most common mistakes manufacturers make during the medical device registration process and explain how they can be avoided.
Common Medical Device Registration Mistakes
Medical device registration is rarely delayed because of a single major problem. More often, applications are held up by avoidable mistakes made during product development, regulatory planning or the preparation of supporting documentation.
By understanding these common pitfalls, manufacturers can reduce regulatory delays, minimise additional costs and improve the likelihood of a successful registration.
1. Assuming Registration Requirements Are the Same Worldwide
Every country has its own regulatory framework for medical devices and IVDs. While many jurisdictions share common principles, the registration process, documentation requirements and regulatory responsibilities differ significantly.
For example, a device that has obtained CE marking under the EU MDR may still require MHRA registration before being placed on the Great Britain market, while entry into the United States involves a completely different FDA regulatory pathway.
Best practice: Develop a market-specific regulatory strategy rather than assuming one approval applies everywhere.
2. Incorrect Device Classification
Incorrectly classifying a device is one of the most common causes of registration delays.
Classification determines the applicable conformity assessment route, the level of regulatory scrutiny and the evidence required to demonstrate compliance. An incorrect classification can result in incomplete Technical Documentation, unnecessary testing or regulatory rejection.
Best practice: Confirm the classification at the earliest possible stage of product development.
3. Incomplete Technical Documentation
Many registration applications are delayed because essential documentation is missing or does not adequately demonstrate compliance with the applicable legislation.
Typical deficiencies include:
- Incomplete Risk Management documentation.
- Insufficient Clinical or Performance Evaluation.
- Missing biological evaluation evidence.
- Inadequate labelling or Instructions for Use.
- Poorly documented design and manufacturing information.
Best practice: Develop Technical Documentation alongside product development rather than waiting until the registration stage.
4. Leaving Regulatory Planning Too Late
Regulatory requirements should influence product development from the very beginning.
Waiting until the device is ready for market often results in additional testing, design changes or significant documentation updates that could have been avoided through early planning.
Best practice: Integrate regulatory strategy into your design and development process from the outset.
5. Forgetting Ongoing Regulatory Responsibilities
Medical device registration is not a one-time activity.
Manufacturers remain responsible for maintaining compliance throughout the product lifecycle, including updating documentation, monitoring device performance, reporting serious incidents and responding to regulatory changes.
Best practice: Maintain an effective Quality Management System that supports continual compliance and regular documentation reviews.
Summary of Common Registration Mistakes
| Common Mistake | Potential Impact | How to Avoid It |
|---|---|---|
| Assuming all countries have the same registration process | Delayed market access | Develop a market-specific regulatory strategy |
| Incorrect device classification | Wrong conformity assessment pathway | Confirm classification early |
| Poor Technical Documentation | Regulatory questions and delays | Prepare documentation throughout development |
| Late regulatory planning | Increased costs and project delays | Integrate regulatory planning from project initiation |
| Neglecting post-market obligations | Loss of ongoing compliance | Maintain an effective QMS and regulatory oversight |
Registration is far more straightforward when regulatory planning begins early and compliance activities are integrated throughout the product lifecycle. Manufacturers that take a proactive approach are generally better prepared for regulatory submissions, market expansion and long-term compliance.
In the next section, we’ll provide a practical medical device registration checklist that summarises the key steps manufacturers should complete before placing a device on the market.
Medical Device Registration Checklist
Before placing a medical device or IVD on the market, manufacturers should ensure that all applicable regulatory requirements have been addressed. While the exact obligations vary depending on the jurisdiction, device classification and intended purpose, the following checklist provides a useful starting point for planning a successful registration.
Medical Device Registration Readiness Checklist
| ✓ | Activity |
|---|---|
| ☐ | Confirm the product meets the definition of a medical device or IVD. |
| ☐ | Determine the correct device classification. |
| ☐ | Clearly define the intended purpose and intended users. |
| ☐ | Identify the regulatory requirements for each target market. |
| ☐ | Prepare Technical Documentation demonstrating regulatory compliance. |
| ☐ | Complete Risk Management in accordance with ISO 14971. |
| ☐ | Conduct the required Clinical Evaluation or Performance Evaluation. |
| ☐ | Complete Biological Evaluation where applicable. |
| ☐ | Prepare compliant labelling and Instructions for Use (IFU). |
| ☐ | Implement an ISO 13485 Quality Management System where required. |
| ☐ | Obtain CE marking or other applicable conformity assessment. |
| ☐ | Complete market-specific registrations (e.g. MHRA, EUDAMED, FDA, ARTG). |
| ☐ | Assign Unique Device Identifiers (UDI) where applicable. |
| ☐ | Appoint an EU Authorised Representative or UK Responsible Person where required. |
| ☐ | Establish Post-Market Surveillance and Vigilance procedures before commercial launch. |
Registration Is an Ongoing Responsibility
Completing the activities above helps manufacturers prepare for market access, but regulatory compliance does not end once a device has been registered or placed on the market.
Manufacturers should continue to:
- Review Technical Documentation regularly.
- Monitor device performance through Post-Market Surveillance (PMS).
- Update Clinical or Performance Evaluation documentation when new evidence becomes available.
- Maintain Risk Management documentation throughout the product lifecycle.
- Report serious incidents to the appropriate regulatory authorities where required.
- Keep registrations and regulatory records up to date following significant changes.
A well-maintained regulatory system supports continued market access, simplifies future product changes and reduces the risk of non-compliance during regulatory inspections or audits.
Need Help with Medical Device Registration?
Navigating medical device registration can be complex, particularly when products are being launched in multiple markets or are subject to different regulatory frameworks.
At Patient Guard, we support manufacturers throughout the entire registration journey, including:
- Regulatory pathway assessments.
- Device classification.
- CE marking and UKCA support.
- Technical Documentation preparation and review.
- Clinical and Performance Evaluation.
- ISO 13485 Quality Management Systems.
- EU Authorised Representative and UK Responsible Person services.
- Post-Market Surveillance and ongoing regulatory support.
Whether you are registering your first medical device or expanding into new international markets, our regulatory specialists can help you identify the most appropriate pathway and prepare the documentation needed for a successful submission.
Conclusion
Medical device registration is not a single regulatory process but a combination of activities that vary depending on the markets in which you intend to place your products. From obtaining CE marking under the EU MDR or IVDR to registering devices with the MHRA, assigning UDIs and meeting international regulatory requirements, manufacturers must understand the obligations that apply to their specific products and jurisdictions.
Successful registration starts with careful planning. Establishing the correct regulatory pathway, preparing robust Technical Documentation and maintaining compliance throughout the product lifecycle are all essential to achieving and retaining market access.
By developing a structured registration strategy and addressing regulatory requirements early, manufacturers can reduce delays, avoid unnecessary costs and bring safe, compliant medical devices to patients more efficiently.
Frequently Asked Questions About Medical Device Registration
Medical device registration is the process of meeting the regulatory requirements that allow a medical device or in vitro diagnostic (IVD) to be legally placed on the market. The exact process varies by country and may include obtaining CE marking, registering devices with the MHRA, assigning Unique Device Identifiers (UDI), appointing an Authorised Representative or completing other market-specific regulatory requirements.
No. CE marking demonstrates that a medical device complies with the requirements of the EU Medical Device Regulation (MDR) or In Vitro Diagnostic Medical Device Regulation (IVDR). Medical device registration refers to the broader regulatory activities required before placing a device on the market, which may also include EUDAMED registration, MHRA registration and other country-specific obligations.
Yes, but the type of registration depends on the country where the device will be marketed. For example, devices supplied in Great Britain must generally be registered with the MHRA, while devices placed on the EU market must comply with the MDR or IVDR and meet applicable registration and conformity assessment requirements.
Registration timelines vary depending on the market, device classification and regulatory pathway. Lower-risk devices may reach the market relatively quickly, while higher-risk devices requiring Notified Body assessment or extensive clinical evidence can take considerably longer. Early regulatory planning helps minimise delays.
The documentation required depends on the applicable legislation and device classification but commonly includes:
- Technical Documentation or Technical File
- Risk Management File
- Clinical Evaluation Report (CER) or Performance Evaluation Report (PER)
- Biological Evaluation (where applicable)
- Device labelling and Instructions for Use (IFU)
- Declaration of Conformity
- Quality Management System documentation
- Post-Market Surveillance documentation
CE marking demonstrates conformity with the applicable European legislation, while MHRA registration is the process of registering eligible medical devices for the Great Britain market. Depending on the applicable transitional arrangements, manufacturers may need both regulatory compliance and MHRA registration before supplying products in Great Britain.
Manufacturers located outside the European Union generally require an EU Authorised Representative before placing devices on the EU market under the MDR or IVDR. The Authorised Representative acts on behalf of the manufacturer for specific regulatory responsibilities defined within the legislation.
Not every jurisdiction explicitly mandates ISO 13485 certification for every device, but an effective Quality Management System is expected under many regulatory frameworks. ISO 13485 is internationally recognised and is often essential for demonstrating compliance, particularly for higher-risk devices and manufacturers operating in multiple markets.
Yes. Many manufacturers develop a global regulatory strategy that supports registration in multiple markets. Although each jurisdiction has its own regulatory requirements, much of the underlying technical documentation, risk management and clinical evidence can often be leveraged across different submissions, subject to local requirements.
Registration is only the beginning of the regulatory lifecycle. Manufacturers must continue to maintain Technical Documentation, perform Post-Market Surveillance, report serious incidents where required, review Clinical or Performance Evaluation evidence, update Risk Management documentation and maintain compliance with applicable regulatory requirements throughout the life of the device.
The first step is determining whether your product is legally considered a medical device or an in vitro diagnostic under the regulations of your target market. Once this has been established, the next steps are to determine the correct device classification and identify the applicable regulatory pathway.
Yes. Patient Guard provides end-to-end regulatory support for medical device and IVD manufacturers, including regulatory pathway assessments, device classification, CE marking, Technical Documentation, Clinical and Performance Evaluation, ISO 13485 Quality Management Systems, EU Authorised Representative services, UK Responsible Person services and ongoing post-market regulatory support. Whether you are bringing a new device to market or expanding internationally, our regulatory specialists can help you navigate the registration process with confidence.
References
This guide is based on the following legislation and official regulatory guidance relating to the registration of medical devices and in vitro diagnostic medical devices within the European Union and key international markets.
| Organisation | Reference | Why it's relevant |
|---|---|---|
| European Union | Regulation (EU) 2017/745 on Medical Devices (MDR) | Establishes the legal framework governing the registration, placing on the market and lifecycle management of medical devices within the European Union. |
| European Union | Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices (IVDR) | Provides the legal framework for the registration, conformity assessment and placing on the market of in vitro diagnostic medical devices within the European Union. |
| European Commission | UDI/Device Registration in EUDAMED | Explains how manufacturers register medical devices and IVDs within EUDAMED, including UDI/device information, registration requirements and ongoing regulatory obligations. |
| Medicines and Healthcare products Regulatory Agency (MHRA) | Register Medical Devices to Place on the Market | Provides official MHRA guidance on registering medical devices and IVDs for the Great Britain market using the Device Online Registration System (DORS). |
| U.S. Food and Drug Administration (FDA) | How to Study and Market Your Device | Provides the FDA's official overview of the U.S. medical device regulatory pathway, including device classification, premarket submissions, establishment registration and device listing. |
| Health Canada | Medical Devices | Provides Health Canada's official guidance on medical device licensing, regulatory requirements and market access within Canada. |
| Swissmedic | Medical Devices | Provides official information on Swiss medical device regulation, market access requirements and the responsibilities of economic operators placing devices on the Swiss market. |
| Therapeutic Goods Administration (TGA) | Medical Devices | Provides Australia's official regulatory framework for medical devices, including inclusion in the Australian Register of Therapeutic Goods (ARTG), conformity assessment and market access requirements. |
Medical device registration requirements vary between jurisdictions and continue to evolve. Manufacturers should always consult the latest published legislation and official regulatory guidance when preparing submissions and maintaining compliance within each target market.
Patient Guards Recent Posts
DCB0129 and Clinical Safety: What Digital Health Manufacturers Need for NHS DTAC
For digital health manufacturers preparing to enter the NHS, clinical safety can be one of the most important—and sometimes misunderstood—parts of DTAC.
It is not enough to demonstrate that your software works.
Manufacturers need to consider what could happen if the technology fails, produces incorrect information, presents information incorrectly, contributes to a workflow error or is used in circumstances that could expose patients to harm.
This is where clinical risk management and DCB0129 become particularly important.
NHS England identifies DCB0129 as the clinical risk management standard for manufacturers of health IT systems. Its counterpart, DCB0160, applies to health organisations deploying and using health IT systems. NHS England states that compliance with these standards is required under the Health and Social Care Act 2012.
For manufacturers working towards NHS DTAC readiness, understanding the distinction—and having the right clinical safety evidence—is essential.
DTAC Requirements Explained: The 5 Areas Digital Health Manufacturers Need to Get Right
If your digital health technology is heading towards the NHS, understanding the Digital Technology Assessment Criteria (DTAC) should be part of your market-access planning.
But one of the biggest mistakes manufacturers can make is treating DTAC as simply another questionnaire to complete.
The questions are only part of the process.
Behind your answers needs to be evidence showing that your technology and organisation have appropriate arrangements for clinical safety, data protection, technical security, interoperability, and usability and accessibility.
These five areas form the core of NHS DTAC. NHS England describes DTAC as national baseline criteria for digital health technologies entering NHS and social care.
For digital health manufacturers, the practical question is therefore not simply:
“Can we complete the DTAC assessment?”
It is:
“Can we demonstrate that our product meets the requirements?”
This guide looks at each of the five DTAC areas, the types of evidence manufacturers should consider and some of the common gaps that can delay NHS readiness.
The Complete Guide to NHS DTAC Compliance for Digital Health Manufacturers
A complete guide to NHS DTAC compliance for digital health manufacturers, covering the five DTAC assessment areas, required evidence, clinical safety, data protection, technical security, interoperability and usability, and how to prepare your digital health technology for NHS procurement.
Patient Guards Related Services
Patient Guards Regulatory Tools
Need Training?
Do you need training on Quality Management Systems or EU MDR/ EU IVDR? then check out our training courses.
